Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | 23.4x - 25.9x | 24.6x |
| Selected Fwd P/E Multiple | 21.7x - 24.0x | 22.8x |
| Fair Value | HK$ 13.62 - HK$ 15.05 | HK$ 14.34 |
| Upside | 12.0% - 23.8% | 17.9% |
| Benchmarks | - | Full Ticker |
| China Pacific Insurance (Group) Co., Ltd. | 260,100.0% | SEHK:2601 |
| The People's Insurance Company (Group) of China Limited | 133,900.0% | SEHK:1339 |
| Hubei Biocause Pharmaceutical Co., Ltd. | 62,700.0% | SZSE:000627 |
| China Life Insurance Company Limited | 262,800.0% | SEHK:2628 |
| Ping An Insurance (Group) Company of China, Ltd. | 231,800.0% | SEHK:2318 |
| ZhongAn Online P & C Insurance Co., Ltd. | 606,000.0% | SEHK:6060 |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| 2601 | 1339 | 627 | 2628 | 2318 | 6060 | |||
| SEHK:2601 | SEHK:1339 | SZSE:000627 | SEHK:2628 | SEHK:2318 | SEHK:6060 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 10.1% | 14.1% | NM- | 13.1% | -3.3% | NM- | ||
| 3Y CAGR | 18.8% | 25.9% | NM- | 28.2% | 7.6% | -19.7% | ||
| Latest Twelve Months | 64.9% | 88.2% | -337.2% | 108.9% | 47.8% | -85.2% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 9.8% | 6.2% | 1.2% | 10.4% | 12.8% | 2.1% | ||
| Prior Fiscal Year | 9.9% | 4.6% | 0.6% | 23.3% | 9.4% | 13.9% | ||
| Latest Fiscal Year | 14.3% | 7.8% | -1.4% | 34.0% | 13.1% | 1.8% | ||
| Latest Twelve Months | 14.3% | 7.8% | -1.9% | 34.0% | 13.1% | 1.8% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 7.8x | 6.8x | -20.8x | 8.1x | 13.0x | 19.2x | ||
| Price / LTM Sales | 0.9x | 0.5x | 0.5x | 2.8x | 0.9x | 0.5x | ||
| LTM P/E Ratio | 6.3x | 6.7x | -24.5x | 8.3x | 6.9x | 27.7x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -24.5x | 6.7x | 8.3x | |||||
| Historical LTM P/E Ratio | -41.7x | 27.7x | 180.8x | |||||
| Selected P/E Multiple | 23.4x | 24.6x | 25.9x | |||||
| (x) LTM Net Income | 603 | 603 | 603 | |||||
| (=) Equity Value | 14,118 | 14,861 | 15,604 | |||||
| (/) Shares Outstanding | 1,469.8 | 1,469.8 | 1,469.8 | |||||
| Implied Value Range | 9.61 | 10.11 | 10.62 | |||||
| FX Rate: CNY/HKD | 0.9 | 0.9 | 0.9 | Market Price | ||||
| Implied Value Range (Trading Cur) | 10.25 | 10.79 | 11.33 | 12.16 | ||||
| Upside / (Downside) | -15.7% | -11.2% | -6.8% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 2601 | 1339 | 627 | 2628 | 2318 | 6060 | |
| Value of Common Equity | 307,933 | 354,364 | 18,923 | 1,030,962 | 917,734 | 16,741 | |
| (/) Shares Outstanding | 13,363.9 | 87,574.7 | 4,940.6 | 72,412.2 | 20,890.9 | 1,469.8 | |
| Implied Stock Price | 23.04 | 4.05 | 3.83 | 14.24 | 43.93 | 11.39 | |
| FX Conversion Rate to Trading Currency | 0.94 | 0.94 | 1.00 | 0.94 | 0.94 | 0.94 | |
| Implied Stock Price (Trading Cur) | 24.60 | 4.32 | 3.83 | 15.20 | 46.90 | 12.16 | |
| Trading Currency | HKD | HKD | CNY | HKD | HKD | HKD | |
| FX Rate to Reporting Currency | 0.94 | 0.94 | 1.00 | 0.94 | 0.94 | 0.94 | |